Crossmark

A stability indicating UPLC method development and validation for the simultaneous estimation of nateglinide and metformin hydrochloride in bulk and tablet dosage form

Crossref DOI link: https://doi.org/10.1186/s43094-023-00503-2

Published Online: 2023-06-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Narikimalli, Ashritha

Galla, Rajitha https://orcid.org/0000-0001-6178-0715
License Information

Text and Data Mining valid from 2023-06-28

Version of Record valid from 2023-06-28
More Information

Article History

Received: 30 September 2022

Accepted: 17 June 2023

First Online: 28 June 2023

Declarations

:

: Not applicable.

: The authors declare no conflict of interest.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below